FindTrial
Sign In

Orencia

DRUG7 trials

Sponsors

Karolinska Institutet, Medical University of Vienna, Bristol-Myers Squibb, Arthritis & Rheumatism Associates, P.C.

Conditions

Rheumatoid ArthritisSjogren's Syndrome

Phase 2

Sjogrens Syndrome Measured by Ultrasound
NCT03411850
Arthritis & Rheumatism Associates, P.C.Sjogren's Syndrome
Start: 2016-05-31End: 2021-12-31Updated: 2021-05-11

Phase 4

Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction
NCT01491815
Karolinska InstitutetRheumatoid Arthritis
Start: 2012-12-14End: 2023-12-31Updated: 2022-07-08
A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action
CompletedNCT01638715
Medical University of ViennaRheumatoid Arthritis
Start: 2012-05-31End: 2018-08-01Updated: 2018-10-31
Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity
NCT02466581
Karolinska InstitutetRheumatoid Arthritis
Start: 2015-02-03End: 2023-12-31Updated: 2022-07-08

Unknown Phase

Description of Joint Population and Assessment of Impact on Health Status of Orencia in Patients With Rheumatoid Arthritis in France. A Database Analysis Based on SFR's ORA Long-term Cohort Study
WithdrawnNCT01694693
Bristol-Myers SquibbRheumatoid Arthritis
Start: 2018-01-31End: 2018-12-31Updated: 2017-05-10
Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL
CompletedNCT02600455
Bristol-Myers SquibbRheumatoid Arthritis
Start: 2013-09-30End: 2016-06-30Updated: 2017-01-13
Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg
CompletedNCT02600468
Bristol-Myers SquibbRheumatoid Arthritis
Start: 2013-09-30End: 2015-12-31Updated: 2017-01-16

Related Papers

Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trial.
2026-04-01
Glucocorticoid treatment in early rheumatoid arthritis is independently associated with increased PCSK9 levels: data from a randomised controlled trial
RMD Open2025-06-01
OP0327 TAPERING AND DISCONTINUATION OF GLUCOCORTICOIDS IN EARLY RHEUMATOID ARTHRITIS: THE RISK OF FLARE
Annals of the Rheumatic Diseases2025-06-01
Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial.
2024-11-145 citations
Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study
RMD Open2024-04-0118 citations
Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis.
2024-03-051 citations
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
2023-07-0929 citations
Torque Teno Virus quantification for monitoring of immunomodulation with biologic compounds in the treatment of rheumatoid arthritis
Lara D. Veeken2021-11-1523 citations
Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis-a spin-off study of the NORD-STAR randomized clinical trial.
2021-07-1311 citations
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial
BMJ2020-12-02108 citations
Head-to-head comparison of aggressive conventional therapy and three biological treatments and comparison of two de-escalation strategies in patients who respond to treatment: study protocol for a multicenter, randomized, open-label, blinded-assessor, phase 4 study.
2017-04-0426 citations